Citation: Gtc. Ko et al., Use of acarbose or bedtime insulin after failure of treatment with conventional oral antidiabetics - A one-year randomised clinical trial, CLIN DRUG I, 21(6), 2001, pp. 401-408
Citation: Gtc. Ko et al., Blood pressure reduction and tolerability of amlodipine versus nifedipine retard in Chinese patients with Type 2 diabetes mellitus and hypertension: a randomized 1-year clinical trial, INT J CL PH, 39(8), 2001, pp. 331-335
Citation: Gtc. Ko et al., Obesity, insulin resistance and isolated low high-density-lipoprotein cholesterol in Chinese subjects, DIABET MED, 18(8), 2001, pp. 663-666
Citation: Gtc. Ko et al., A low socio-economic status is an additional risk factor for glucose intolerance in high risk Hong Kong Chinese, EUR J EPID, 17(3), 2001, pp. 289-295
Citation: Sc. Lee et al., The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: Evidence for associations with type 2 diabetes and cholesterol levels, CLIN ENDOCR, 54(4), 2001, pp. 541-546
Citation: Sc. Lee et al., Factors predicting the age when type 2 diabetes is diagnosed in Hong Kong Chinese subjects, DIABET CARE, 24(4), 2001, pp. 646-649
Authors:
Ng, MCY
Lee, SC
Ko, GTC
Li, JKY
So, WY
Hashim, Y
Barnett, AH
Mackay, IR
Critchley, JAJH
Cockram, CS
Chan, JCN
Citation: Mcy. Ng et al., Familial early-onset type 2 diabetes in Chinese patients - Obesity and genetics have more significant roles than autoimmunity, DIABET CARE, 24(4), 2001, pp. 663-671
Citation: Sc. Lee et al., Risk factors for cataract in Chinese patients with type 2 diabetes: evidence for the influence of the aldose reductase gene, CLIN GENET, 59(5), 2001, pp. 356-359
Authors:
Ko, GTC
Tang, J
Chan, JCN
Sung, R
Wu, MMF
Wai, HPS
Chen, R
Citation: Gtc. Ko et al., Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance, BR J NUTR, 85(2), 2001, pp. 239-242
Authors:
Chan, WB
Chan, JCN
Chow, CC
Yeung, VTF
So, WY
Li, JKY
Ko, GTC
Ma, RCW
Cockram, CS
Citation: Wb. Chan et al., Glycaemic control in type 2 diabetes: the impact of body weight, beta-cellfunction and patient education, QJM-MON J A, 93(3), 2000, pp. 183-190
Citation: Gtc. Ko et al., Cardiovascular disease in Chinese type 2 diabetic women is associated witha prolonged QTc interval, INT J CARD, 76(1), 2000, pp. 75-80
Citation: Sc. Lee et al., Diabetes in Hong Kong Chinese - Evidence for familial clustering and parental effects, DIABET CARE, 23(9), 2000, pp. 1365-1368
Citation: Gtc. Ko et al., No relationship between antibodies to GAD and microangiopathic complications in young Chinese diabetic patients, DIABET CARE, 23(7), 2000, pp. 1045-1046
Citation: Gtc. Ko et al., Combined use of fasting plasma glucose and HbA(1c) predicts the progression to diabetes in Chinese subjects, DIABET CARE, 23(12), 2000, pp. 1770-1773
Citation: Jcn. Chan et al., Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients, KIDNEY INT, 57(2), 2000, pp. 590-600
Citation: Gtc. Ko et al., Hyperfibrinogenaemia did not improve after treating hyperglycaemia in Chinese type 2 diabetic patients, ANN CLIN BI, 37, 2000, pp. 655-661
Citation: Gtc. Ko et al., Diabetic microangiopathic complications in young Chinese diabetic patients: A clinic-based cross-sectional study, J DIABET C, 13(5-6), 1999, pp. 300-306